Skip to content

Investigating the therapeutic effect of PRP (Platelet-Rich Plasma) in ovarian function

Investigating the therapeutic effect of PRP (Platelet-Rich Plasma) in improving ovarian function in patients with infertility

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181216042006N2
Enrollment
20
Registered
2023-04-11
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with poor response to ovarian stimulation. Female infertility associated with anovulation

Interventions

Intervention group: (Women with poor response to ovarian stimulation) The statistical population of the study will be 20 infertile women referred to Roish Birjand clinic with poor response to ovarian

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age range from 25 to 45 years The amount of FSH hormone is higher than 12 The amount of AMH hormone is lower than 1 Poor response to ovulation stimulating drugs in previous cycles Donor egg candidate

Exclusion criteria

Exclusion criteria: The presence of any ovarian cyst confirmed by a gynecologist People with polycystic ovary confirmed by a gynecologist People with underlying medical diseases (hypertension and diabetes)

Design outcomes

Primary

MeasureTime frame
FSH hormone level. Timepoint: A few days before the injection and the first menstrual cycle after the injection. Method of measurement: Measurement in the laboratory.;AMH hormone level. Timepoint: A few days before the injection and the first menstrual cycle after the injection. Method of measurement: Measurement in the laboratory.;LH hormone level. Timepoint: A few days before the injection and the first menstrual cycle after the injection. Method of measurement: Measurement in the laboratory.;AFC number. Timepoint: A few days before the injection and the first menstrual cycle after the injection. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtena mansouri

Birjand University of Medical Sciences

mansouri_atena@bums.ac.ir+98 56 3238 1259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026